A Phase 2a, Proof of Concept Trial, Testing Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema
Phase of Trial: Phase II
Latest Information Update: 08 May 2017
At a glance
- Drugs Delgocitinib (Primary)
- Indications Eczema
- Focus Proof of concept; Therapeutic Use
- Sponsors LEO Pharma
- 26 Oct 2016 Status changed from active, no longer recruiting to completed.
- 26 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 22 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.